Barinthus Biotherapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	65.86	70.46	110.66	142.09	194.39	214.05
Cash & Short-Term Investments	65.86	70.46	110.66	142.09	194.39	214.05
Cash Growth	-33.56%	-36.33%	-22.12%	-26.90%	-9.19%	394.74%
Accounts Receivable	-	-	-	-	5.85	0.02
Other Receivables	1.23	1.11	7.14	4.91	4.54	6.23
Total Trade Receivables	1.23	1.11	7.14	4.91	10.39	6.25
Other Current Assets	5.57	6.23	7.94	9.91	8.27	6.46
Total Current Assets	72.66	77.79	125.74	156.91	213.04	226.77
Net Property, Plant & Equipment	4.9	5.16	11.76	19.4	15.71	9.09
Other Intangible Assets	13.67	14.29	21.95	25.11	28.27	31.43
Goodwill	-	-	-	12.21	12.21	12.63
Other Long-Term Assets	0.91	0.93	0.88	0.88	0.98	0.8
Total Assets	92.14	98.17	160.33	214.51	270.21	280.72
Accounts Payable	0.99	0.35	2.47	1.6	3.75	2.42
Accrued Expenses	8.69	6.25	9.53	9.21	8.06	7.88
Short-Term Debt	-	-	-	-	-	0.16
Current Portion of Leases	2.01	2.02	1.92	1.79	0.43	0.52
Unearned Revenue	0.32	1.4	1.74	-	-	0.18
Total Current Liabilities	12	10.02	15.66	12.6	12.24	11.16
Long-Term Leases	9	9.26	10.09	11.19	8.34	6.54
Other Long-Term Liabilities	4.66	4.6	4.45	3.72	6.42	10.46
Total Long-Term Liabilities	13.66	13.86	14.54	14.91	14.76	17
Total Liabilities	25.67	23.88	30.19	27.51	27	28.15
Preferred Stock	0.09	0.09	0.09	0.09	0.09	0.09
Common Stock	0	0	0	0	0.01	0.01
Additional Paid-in Capital	394.5	393.94	393.47	386.6	379.5	369.1
Accumulated Other Comprehensive Income	-18.56	-15.73	-25.87	-23.32	-33.46	-8.49
Retained Earnings	-309.63	-304.09	-237.66	-176.59	-103.24	-108.59
Total Common Shareholders' Equity	66.4	74.21	130.03	186.78	242.9	252.13
Minority Interest	0.08	0.08	0.11	0.21	0.31	0.44
Shareholders' Equity	66.48	74.29	130.14	187	243.2	252.56
Total Liabilities & Equity	92.14	98.17	160.33	214.51	270.21	280.72
Total Debt	11.01	11.28	12.01	12.98	8.77	7.22
Net Cash (Debt)	54.85	59.18	98.66	129.11	185.61	206.83
Net Cash Growth	-7.31%	-40.02%	-23.59%	-30.44%	-10.26%	397.17%
Net Cash Per Share	1.35	1.46	2.51	3.36	4.86	7.99
Book Value	66.4	74.21	130.03	186.78	242.9	252.13
Book Value Per Share	1.63	1.83	3.30	4.87	6.36	9.74
Tangible Book Value	52.73	59.92	108.08	149.47	202.42	208.07
Tangible Book Value Per Share	1.30	1.48	2.75	3.89	5.30	8.04